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MALDI-MS imaging enables the relative quantification and spatial expression profiling of thousands of peptides within and between tissues. Using tissue microarrays (TMAs) can facilitate the acquisition of data from large cohorts of patients [1] , but relative to the number of resolvable ion species, the sample sizes remain small -less than 100 patients represented in a typical study, although there are some notable exceptions [2] . Classification at a patient level of such data is of clinical interest, but classical approaches to classification, such as linear discriminant analysis (LDA), do not apply without modifications such as prior feature selection or regularisation. In this paper we suggest a method for dimension reduction via variable selection prior to classification and demonstrate its effectiveness when applied to the data of [3] , which consist of MALDI-MS imaging data collected from TMAs of formalin-fixed paraffin-embedded (FFPE) primary endometrial carcinoma tissue. For these endometrial cancer data it is of interest to distinguish between patients with lymph node metastasis (LNM) and those without.
Endometrial cancer is the most common gynaecological malignancy in Australia with 2256 diagnosed cases in 2010 and 381 associated deaths in 2011 [4] . The presence or absence of lymph node metastasis (LNM) is the most important prognostic factor in endometrial cancer as patients with localised disease have a 5 year survival rate of 96%, which drops to just 17% for patients with metastatic disease [5] . Accurately staging endometrial cancer is difficult and a large percentage of patients are misclassified prior to treatment [6] . Although the presence of LNM is confirmed in only around 15% of cases [7, 8] , the majority of endometrial cancer patients undergo radical treatment including the removal of pelvic lymph nodes as a precautionary measure to compensate for our current inability to accurately stage the disease. Lymph node removal is associated with significant complications including lower extremity lymphoedema, which has been described in up to 38% of patients [9] . A classification system based around predictive tissue markers of metastasis would greatly benefit stage I endometrial cancer patients by helping determine optimal treatment strategies that avoid unnecessary, invasive procedures.
The sample preparation of the endometrial TMAs included citric acid antigen retrieval [10] , trypsin digestion, addition of internal calibrants [11] , and matrix deposition. Further details on the data acquisition for the endometrial data are available in [3] . As part of the data acquisition peak-picking was performed through proprietary software (flexControl v3.0.1 and flexImaging v4.0.1, Bruker Daltonik, http://www.bruker.com). All our analyses 3 are carried out solely on the monoisotopic peaks detected by this method. These peak-data are about two orders of magnitude smaller and result in much faster computation times while preserving important information.
Two sections (technical replicates) of two TMAs were analysed and tumour regions annotated by a pathologist. In this analysis, the only information we use about each spectrum is which patient it belongs to and whether the pathologist's annotations include it as tumour.
After consideration of the patient clinical data it was determined that 43 patients suitable for the study are represented across the two TMAs. Of these 43 patients, 16 are LNM positive, 27 are negative. Details on the endometrial cancer project from which these data originate are available in [3] .
We construct 0.25Da wide, non-overlapping bins which are the variables in our analyses.
In addition we repeat the analyses for shifted bins. Our final prediction combines the corresponding results from the individual analyses, using a majority rule. Details regarding the choice of bins, shifted-bin analyses and majority rule are given in the supplementary information.
For each patient, spectra were averaged for each m/z bin. These averages are assembled into data matrices with 43 columns corresponding to the patients represented in the study, and 4582 rows corresponding to m/z bins with at least one peak in them in at least one spectrum (4570 and 4584 in the two shifted-bin analyses respectively). This resulting data matrix is what will be used in all following analyses. We centre the rows of these data matrices, and refer to these centred data as X.
As previously mentioned, classical approaches to classification such as LDA do not apply to HDLSS data without modifications. Different solution paths exist in the literature which include replacing the classical LDA by its Naive Bayes version, see [12, Section 13.2.1]. Other methods that are directly applicable to HDLSS data include Distance Weighted Discrimination of [13] , kernel methods -see [14] , and regularisation approaches which make use of generalised inverses, ridge-like estimates of the covariance matrix, or Lasso and elastic net type classification -see [15, 16] and references therein.
A different solution path consists of reducing the number of variables or features first, and then applying the chosen classifier to the reduced data. In MALDI-MS imaging data PCA is a popular feature reduction method, see [17, 18] and references therein. More recently [19] have suggested the use of PCA on MALDI-MS imaging data from TMAs in a classification 4 context. For a generic reference to PCA see [20] and [12, Chapter 2 and Section 4.8].
Other feature reduction approaches used in proteomics include the application of univariate tests such as Wilcoxon rank-sum statistics or t-tests -see [21, 22] . For high-dimensional data [23] ranked the variables by applying t-tests simultaneously to all variables and analysed the performance of this approach. We follow a related path, based on Canonical Correlation Analysis (CCA), and select the 'best' original variables in a supervised manner prior to classification. The selected variables do not require any interpretation, as they are simply the m/z bins. Our approach contains the approach of [23] as a special case, and does not require tuning parameters as regularisation-type methods do.
In CCA the data are split into two sets of variables and the linear combinations of variables in each subset with the strongest correlation are determined. Typically this correlation is much stronger than that of any individual pair of variables from the two subsets. In a regression context the correlation between a response and the predictor variables shows the relative strength of the response on the individual predictors. In a classification framework, we use class labels of observations as one subset of variables, and all other variables as the second subset. For our data, the class labels are the LNM status, and the variables are all m/z bins.
It is beyond the scope of this paper to review the different approaches mentioned above or to show detailed comparisons. However, because of the repeated use of PCA for MALDI-MS data, we include a performance comparison of our proposed method with that based on feature reduction with PCA. We note that our CCA-based variable selection is supervised, while PCA does not use the class labels in its feature reduction. As a consequence PCA may not find features that are optimal for predicting class membership. In addition, our suggested CCA-based approach simply ranks the original variables, here m/z bins, and picks the best, while PCA transforms the original variables and results in features that are linear combinations of all m/z bins. While we expect to relate the 'best' CCA masses to biomarkers, no such interpretation is possible for the PCA features. In our results, shown in Figure 1 and Figure 2 , we will see the dramatic improvement in prediction that can be achieved with the supervised CCA-based variable selection compared to the unsupervised PCA-based dimension reduction.
In the context of MALDI-MS data, CCA has been used in finding correlations between datasets collected from the same tissue using different imaging techniques [24] . These authors 5 use CCA in its standard form: finding correlations between two subsets of variables that belong to a natural partition -m/z values collected using one imaging technique, and m/z values collected using the second imaging technique. CCA has also been used in a classification context [25] , although in an exploratory manner -plotting the strongest correlation between their data and their prediction variable to observe a linear relationship.
In this paper we also use the first and strongest correlation obtained from CCA, but we deviate from the conventional approach in that we explicitly use the information inherent in the first direction vector for variable selection. CCA-based variable selection as suggested by [26] is further described in [12, Sections 13.3.1 and 13.3.3], and references therein. We modify their approach for our data, essentially by using centred labels. Here we briefly introduce our variable ranking approach, but further details, motivation, and comments can be found in the supporting information. Let X be a d×n centred data matrix whose columns represent observations (patients), and whose rows represent variables (m/z bins). Let y be a 1 × n vector of (centred) class labels −2n + n and 2n − n corresponding to the same n observations as the columns of X, where n + (n − ) is the number of observations in the positive (negative)
class. The key idea is to exploit the relationship between X and y. Details describing how we use CCA are included in the supporting information, but essentially we will be interested in the vector φ, which satisfies
The vector φ contains the weights for the linear combination of variables, or rows of X, which gives rise to the strongest absolute correlation with y. Variable reduction to k variables is obtained by selecting variables corresponding to the k highest entries of φ by absolute value.
In what follows, LDA refers to Fisher's linear classification as described in [12, Section 4.3] .
LDA finds the direction which maximises the between-class variance and simultaneously minimises the within-class variance of the data. We will use the term CCA-LDA to refer to the process of first using the CCA variable selection to perform a dimension reduction step, and then apply LDA to the selected variables. Similarly, we will use the term PCA-LDA to refer to the process of first performing PCA dimension reduction, and then apply LDA to the selected variables. We measure the performance of these methods by Leave-One-Out (LOO) cross-validation. LOO cross-validation is an iterative process where in each iteration one observation is left out, the classification rule is trained on the remaining data, and tested on the left-out observation -assigning it a class label. This process is repeated until all observations have been assigned class labels in the 'testing' step. Incorrectly assigned observations are counted as LOO misclassification. We use LOO cross-validation rather than a more traditional training/ testing design (where separate datasets are used for the training and testing steps) because of the relatively small number of observations (n = 43).
We examined the effect of the parameters such as regions of tissue and data form as variations of the computational pipeline. In particular we consider the variations listed below and implement all possible combinations of these choices in order to determine which parameters are most important for classification.
• Data form: using raw intensities (I), log-intensities (log(I + 1)), peak areas, signal-tonoise ratios or binary presence/ absence of peaks.
-For non-binary data forms, absence of peaks: When averaging spectra in which some m/z bins contains no peaks, the absence of peaks is included as a zero value, or ignored and not be included in the average.
-For binary data, spatial smoothing: The spatially smoothed binary data as described in [27] is used with smoothing parameters 0, 0.15, or 0.25 where 0 corresponds to no smoothing.
• Regions of tissue: all spectra, or spectra from annotated tumour regions only. Restricting to only annotated tumour regions represents a reduction in the total number of spectra from 123561 to 45877 (∼ 37%) in the endometrial TMA data.
Our analyses showed that data form was the only factor that consistently affected classification performance, with log-intensity data performing best, and binary data typically performing second best.
Overall, the CCA-LDA outperformed PCA-LDA. A typical case can be seen in Figure 1 in which we compare our CCA-LDA with PCA-LDA using the same parameter settings -logintensity data with zeroes included for absent peaks in the averaging step, and restricting to only annotated tumour regions. indicates that CCA-LDA results in a LOO misclassification of one when the best 23 CCA-selected variables are used in LDA for this particular scenario (binary data with a 0.25-smooth and restricting to spectra from regions annotated as tumour only). The figure clearly shows that CCA-LDA consistently achieves better LOO misclassification than PCA-LDA on these data.
